Archives

by in
Entry Author Date Location
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News 09/14/11 Boston
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
Pfizer Forms $100M Research Partnership with Boston-Area Schools and Hospitals 06/08/11 Boston
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank 06/03/11 San Diego
Pharma-Academic Alliances: What the Numbers Don’t Tell You 05/10/11 Seattle
FDA Panel OKs Vertex Drug, Dyax Works With FivePrime, Genzyme Amends Anika Lawsuit, & More Boston-Area Life Sciences News 04/29/11 Boston
Regeneron Reports Positive Results in Colon Cancer Trial 04/26/11 New York
Planting Seeds for Massachusetts’ Future 04/22/11 Boston
Sanofi, Stanford Form Alliance 04/18/11 San Francisco
Aveo Adds Termeer to Board, Monsanto Partners With Atlas, Biogen Drug Meets Clinical Goal, & More Boston-Area Life Sciences News 04/15/11 Boston
Blueprint Medicines Brings In $40M, Led by Third Rock, for Targeted Cancer Therapies 04/11/11 Boston
Zacharon Nabs $210M Deal With Pfizer to Tackle Orphan Diseases 04/07/11 San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter 03/31/11 Boston
Columbia Teams With Sanofi on Diabetes Research 03/28/11 New York
Synageva Grabs $25M for Rare Diseases Drug Pipeline 03/21/11 Boston
Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News 03/11/11 Boston
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry 03/10/11 San Francisco
Kahoots Bought By RentJuice, Skyhook Enlists Sony, MassChallenge Adds $1M from MA, & More Boston-Area Deals News 03/09/11 Boston
Report: Genzyme Chief Could Reap $221.2M in Sanofi Deal 03/08/11 Boston
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News 03/04/11 Boston
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche 03/03/11 Boston
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer 02/25/11 Boston
iAMscientist, Backed by George Whitesides, Tries to Help Firms and Institutes Find Top Talent 02/23/11 Boston
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV 02/23/11 Seattle
Constant Contact Buys Bantam Live, Forest Pays $1.2B for Clinical Data, Paydiant Scores $7.6M, & More Boston-Area Deals News 02/23/11 Boston
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News 02/18/11 Boston
Genzyme, After Months of Holding Out, Agrees to be Sold to Sanofi-Aventis for $20.1B 02/16/11 Boston
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
Page 1 of 6 next page »